3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Leukemia, Hairy Cell
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Agnosia
1
Interventions
Nivolumab
19
pembrolizumab
17
Ipilimumab
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
7
CTLA-4 Antigen
6
binimetinib
5
Opdualag
5
trametinib
4
relatlimab
4
dabrafenib
3
Standard of Care
3
Paclitaxel
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Blood Specimen Collection
3
ulixertinib
2
sargramostim
2
lenvatinib
2
fludarabine phosphate
2
fludarabine
2
encorafenib
2
capivasertib
2
cabozantinib
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Taxes
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Acetaminophen
×
30 days
×
Clear all
No trials found.